News and Press Releases
Calypso Enters into Agreement to Be Acquired by Novartis
Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indications The acquisition of Calypso gives Novartis...
Category: Biotechnology
Posted: January 8, 2024
CordenPharma & pHLIP announce strategic alliance to develop pHLIP LNP targeted delivery platform for RNA & gene therapies
4 January 2024 – Basel, Switzerland / Providence, RI, USA – CordenPharma International (Basel, Switzerland) and pHLIP, Inc. (Kingston, RI) are pleased to announce their strategic alliance to collaborate in...
Category: Drug Delivery, Drug Discovery
Posted: January 5, 2024
Headlands Research Announces Partnership with Sahara Behavioral Health
The collaboration improves access to clinical research and investigational treatments while supporting participant recruitment efforts in Arizona 4 January 2024 -- California, US -- Headlands Research, a leading multinational network...
Category: Clinical Trials
Posted: January 5, 2024
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
5 January 2024 -- Helsinki, Finland -- Nanoform Finland, the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV) in a trial to evaluate...
Category: Clinical Trials
Posted: January 5, 2024
Aptar Digital Health and Gerresheimer Collaborate to develop integrated solution for subcutaneous cancer therapy
Collaboration aims to deliver an innovative solution to improve overall patient treatment adherence and clinical outcomes 4 January 2024 – Crystal Lake, Illinois US – Aptar Digital Health, a global...
Category: Drug Delivery, Logistics, Manufacturing and Packing, Pharmaceutical
Posted: January 5, 2024
Blue Spark Technologies Adds MaryAnne Rizk to Board of Advisors
Cutting-Edge Remote Patient Monitoring Technology Enhances Leadership with the Appointment of Board of Advisors 4 January 2024 -- Ohio, US -- Blue Spark Technologies, a proven innovative digital health technology...
Category: Biotechnology
Posted: January 4, 2024
New partnership aims to advance vaccine against MERS coronavirus
CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...
Category: Clinical Trials
Posted: January 2, 2024
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase 2 Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
21 December 2023 -- North Carolina, US -- The PPD clinical research business of Thermo Fisher Scientific Inc, the world leader in serving science, has been selected by the Biomedical...
Category: Clinical Trials
Posted: December 21, 2023
Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer
The submission is supported by data from the Phase 3 MARIPOSA study, which featured in a Late-Breaking Presidential Symposium session at the 2023 ESMO CongressLazertinib is a highly selective, central...
Category: Clinical Trials
Posted: December 21, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries
20 December 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimising pharmacovigilance...
Category: Clinical Trials
Posted: December 20, 2023
Rentschler Biopharma announces major client project for new US facility at Milford, MA Site
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year 20 December 2023 – Laupheim, Germany and Milford, MA, US – Rentschler Biopharma SE, a leading...
Category: BioManufacturing, Logistics, Manufacturing and Packing
Posted: December 20, 2023
Recipharm harmonises its global quality operations with Veeva Vault Quality
Leading CDMO adopts Veeva Vault QMS, Vault QualityDocs, and Vault Training to standardise quality processes and manage GxP content across its organisation 19 December 2023 – Veeva Systems today announced...
Category: Logistics, Manufacturing and Packing, Pharmaceutical
Posted: December 19, 2023
Aptar Digital Health and Legit.Health partner to improve patient experience in immuno-dermatology
Collaboration will integrate Legit.Health's innovative technology into Aptar Digital Health’s proprietary digital health platform to better manage and treat skin conditions 14 December 2023 – Crystal Lake, Illinois, US –...
Category: BioManufacturing, Logistics, Manufacturing and Packing
Posted: December 19, 2023
AscellaHealth Identifies Key Health Trends for 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry
19 December 2023 – Dublin, Ireland – AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, today publishes forecasted specialty pharmacy industry trends for 2024, as industry stakeholders brace...
Category: BioManufacturing, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: December 19, 2023
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US
Biosynth to offer complex chemistry solutions at greater scales following acquisition of VIO Chemicals
Expansion of capacity for reliable, sustainable, and flexible manufacturing solutions at any production scale. 19 December 2023 – Biosynth, a supplier of critical raw materials to the life science industry,...
Category: BioManufacturing, Manufacturing and Packing
Posted: December 19, 2023
